Rajah Menon
Vorstandsvorsitzender bei AR Pharma, Inc.
Profil
Rajah Menon is the founder of Kard Scientific, Inc. founded in 2002.
He is currently the Chief Executive Officer & Director at AR Pharma, Inc. Mr. Menon was the President & Director at BioVie, Inc. from 2013 to 2016.
Mr. Menon received his undergraduate degree from Amherst College in 2000.
Aktive Positionen von Rajah Menon
| Unternehmen | Position | Beginn |
|---|---|---|
AR Pharma, Inc.
 AR Pharma, Inc. BiotechnologyHealth Technology AR Pharma, Inc. provides health care services. It targets hematological malignancies and underserved orphan diseases through development of personalized antibody and biologic therapies. The company is headquartered in Woburn, MA. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Rajah Menon
| Unternehmen | Position | Ende |
|---|---|---|
| BIOVIE INC. | Präsident | 11.04.2016 |
Kard Scientific, Inc.
 Kard Scientific, Inc. Miscellaneous Commercial ServicesCommercial Services Kard Scientific, Inc. provides contract research services. It offers in vivo and in vitro pharmacology and preclinical research. The company was founded by Rajah Menon in 2002 and is headquartered in Cambridge, MA. | Gründer | - |
Ausbildung von Rajah Menon
| Amherst College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOVIE INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Kard Scientific, Inc.
Kard Scientific, Inc. Miscellaneous Commercial ServicesCommercial Services Kard Scientific, Inc. provides contract research services. It offers in vivo and in vitro pharmacology and preclinical research. The company was founded by Rajah Menon in 2002 and is headquartered in Cambridge, MA. | Commercial Services |
AR Pharma, Inc.
AR Pharma, Inc. BiotechnologyHealth Technology AR Pharma, Inc. provides health care services. It targets hematological malignancies and underserved orphan diseases through development of personalized antibody and biologic therapies. The company is headquartered in Woburn, MA. | Health Technology |
